Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
- Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
- Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
- Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
- Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver
- Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.
- Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
- Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
- A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
- Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver
- A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
- Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose
- Effect of Pioglitazone on T2DM Patients With COVID-19
- Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases
- Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
- Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke
- Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
- Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome
- Dapagliflozin Plus Pioglitazone in T1DM
- Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease
- Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism
- Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary Syndrome
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy
- Insulin Signaling in Skeletal Muscle
- Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes
- Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome
- Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome
- An Extension Study of PEAK Trial
- Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
- Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
- Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
- Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
- A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers
- Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin
- Fatty Liver Study in Patients With Type II Diabetes
- Ovulation Induction in Clomiphene Citrate Resistant PCO Women
- The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients
- Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management
- Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
- Trial for People With Established Type 2 Diabetes During Ramadan
- Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
- The Practical Evidence of Antidiabetic Combination Therapy in Korea
- Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
- Glycemic Durability After Metformin Failure
- Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.
- Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients
- Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients
- Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
- Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
- Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
- Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
- Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
- Liraglutide Hospital Discharge Trial
- Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
- Triple Therapy in Type 2 Diabetic Patients
- Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fasting Conditions
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes
- Metabolic Abnormalities in HIV-infected Persons
- Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients
- Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects
- The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
- Effects of Different Early Intensive Therapies on Long-term β-cell Function
- Pioglitazone and Metformin in Diabetic Children
- Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes
- Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
- Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
- A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)
- Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
- Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
- Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea
- Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
- Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
- Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
- The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
- Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
- A Study in Participants With Type 2 Diabetes Mellitus
- Fracture Risk With Thiazolidinediones
- Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin
- Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
- Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
- Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes
- Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes
- A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
- Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
- Safety and Efficacy of Albiglutide in Type 2 Diabetes
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
- Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
- Pioglitazone Versus Metformin in Type 2 Diabetes
- Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
- Response To Oral Agents in Diabetes (ROAD)- Pilot Study
- Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study
- Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
- Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.
- Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
- Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.
- Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
- Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
- Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
- Bone Turnover in Type 2 Diabetes Patients
- Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
- Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
- Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
- Pioglitazone Incretin Study
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
- A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
- A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
- MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
- Safety Study of Pioglitazone Compared To Glyburide on Liver Function
- Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
- Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
- Medication in Early Diabetes (MED) Study
- Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
- Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
- "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM
- Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
- Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
- Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
- A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
- Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
- Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus
- Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
- Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
- A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics
- Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
- Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
- Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin
- Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance
- Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
- Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
- Treating Nonalcoholic Steatohepatitis With Pioglitazone
Clinical trials list
click for details